2021 EHA建议:高铁血红蛋白血症的诊断和治疗

2021-09-01 欧洲血液学协会 Am J Hematol

高铁血红蛋白血症是一种罕见的疾病,血红蛋白分子的辅基血红素中的亚铁被氧化成三价铁,即成为高铁血红蛋白(MHb),同时失去带氧功能。可由遗传或后天因素引起。

中文标题:

2021 EHA建议:高铁血红蛋白血症的诊断和治疗

英文标题:

Recommendations for diagnosis and treatment of methemoglobinemia

发布机构:

欧洲血液学协会

发布日期:

2021-09-01

简要介绍:

高铁血红蛋白血症是一种罕见的疾病,血红蛋白分子的辅基血红素中的亚铁被氧化成三价铁,即成为高铁血红蛋白(MHb),同时失去带氧功能。可由遗传或后天因素引起。本文主要针对高铁血红蛋白血症的诊断,不同年龄人群的管理提供指导建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 EHA建议:高铁血红蛋白血症的诊断和治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=756611c0021828f1, title=2021 EHA建议:高铁血红蛋白血症的诊断和治疗, enTitle=Recommendations for diagnosis and treatment of methemoglobinemia, guiderFrom=Am J Hematol, authorId=0, author=, summary=高铁血红蛋白血症是一种罕见的疾病,血红蛋白分子的辅基血红素中的亚铁被氧化成三价铁,即成为高铁血红蛋白(MHb),同时失去带氧功能。可由遗传或后天因素引起。, cover=https://img.medsci.cn/2021910/1631282457662_5579292.jpg, journalId=0, articlesId=null, associationId=1164, associationName=欧洲血液学协会, associationIntro=欧洲血液学协会(European Haematology Association, EHA)旨在促进血液学领域的诊治、研究和教育, 目前拥有来自世界各地的成员4000多名。学会工作主要是组织年会、制定教育计划、出版刊物、宣传普及血液学学术成果, 进而促进欧洲内外血液病学专家学者的研究。, copyright=0, guiderPublishedTime=Wed Sep 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">高铁血红蛋白血症是一种罕见的疾病,血红蛋白分子的辅基血红素中的亚铁被氧化成三价铁,即成为高铁血红蛋白(MHb),同时失去带氧功能。可由遗传或后天因素引起。本文主要针对高铁血红蛋白血症的诊断,不同年龄人群的管理提供指导建议。</span></p>, tagList=[TagDto(tagId=114678, tagName=高铁血红蛋白血症)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=94609, guiderKeyword=获得性高铁血红蛋白血症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4174, appHits=43, showAppHits=0, pcHits=516, showPcHits=4131, likes=0, shares=0, comments=4, approvalStatus=1, publishedTime=Mon Sep 13 00:02:40 CST 2021, publishedTimeString=2021-09-01, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Sep 10 22:04:06 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 10:41:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 EHA建议:高铁血红蛋白血症的诊断和治疗.pdf)])
2021 EHA建议:高铁血红蛋白血症的诊断和治疗.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1184716, encodeId=94a51184e16c0, content=打卡学习,加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Sat Jan 15 23:55:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061968, encodeId=4c63106196825, content=非常好的文章,受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:59:20 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051912, encodeId=09ab105191265, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 12:07:12 CST 2021, time=2021-09-16, status=1, ipAttribution=)]
    2022-01-15 1e22b426m70(暂无匿称)

    打卡学习,加油

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1184716, encodeId=94a51184e16c0, content=打卡学习,加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Sat Jan 15 23:55:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061968, encodeId=4c63106196825, content=非常好的文章,受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:59:20 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051912, encodeId=09ab105191265, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 12:07:12 CST 2021, time=2021-09-16, status=1, ipAttribution=)]
    2021-10-19 湘雅科教

    非常好的文章,受益匪浅。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1184716, encodeId=94a51184e16c0, content=打卡学习,加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Sat Jan 15 23:55:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061968, encodeId=4c63106196825, content=非常好的文章,受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:59:20 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051912, encodeId=09ab105191265, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 12:07:12 CST 2021, time=2021-09-16, status=1, ipAttribution=)]
    2021-09-16 湘雅科教

    受益匪浅

    0